brimonidine tartrate has been researched along with enkephalin, d-penicillamine (2,5)- in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gnegy, ME; Mangels, LA | 1 |
Fairbanks, CA; Guo, XH; Loh, HH; Stone, LS | 1 |
2 other study(ies) available for brimonidine tartrate and enkephalin, d-penicillamine (2,5)-
Article | Year |
---|---|
Cyclic AMP accumulation alters calmodulin localization in SK-N-SH human neuroblastoma cells.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Alprostadil; Analgesics; Brimonidine Tartrate; Bucladesine; Calcium; Calmodulin; Carbachol; Cell Line; Colforsin; Cyclic AMP; Cytosol; Edetic Acid; Egtazic Acid; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Humans; Kinetics; Neuroblastoma; Quinoxalines; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1992 |
DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice.
Topics: Animals; Brimonidine Tartrate; Dose-Response Relationship, Drug; Drug Synergism; Enkephalin, D-Penicillamine (2,5)-; Mice; Mice, Inbred C57BL; Mice, Knockout; Pain Measurement; Quinoxalines; Receptors, Opioid, mu; Spinal Cord | 2003 |